Serum opsonins and chemotactins in neutropenic oncology patients.
Serum opsonins and chemotactins, C3 and C5, were studied in neutropenic oncology patients. Our data indicate that these individuals possess normal serum chemotactins and adequate opsonin activity regardless of disease status or prior chemotherapy. Their sera should therefore support function of transfused granulocytes.